Cargando…
Refractory Pediatric Fibrostenotic Eosinophilic Esophagitis Treated With Dupilumab
Eosinophilic esophagitis (EoE) is a progressive inflammatory disease of the esophagus. Untreated or uncontrolled disease over time can lead to the development of fibrosis and formation of strictures. Once the patient develops strictures, it is difficult to treat with the available medical therapies...
Autores principales: | Gangadharan Nambiar, Gopinathan, Rahhal, Riad, Davis, Benjamin P., Xiong, Yiqin, Cheung, Donna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663132/ https://www.ncbi.nlm.nih.gov/pubmed/36382335 http://dx.doi.org/10.14309/crj.0000000000000887 |
Ejemplares similares
-
Progression from an Inflammatory to a Fibrostenotic Phenotype in Eosinophilic Esophagitis
por: Koutlas, Nathaniel T., et al.
Publicado: (2017) -
Early Comparison of Inflammatory vs. Fibrostenotic Phenotype in Eosinophilic Esophagitis in a Multicenter Longitudinal Study
por: Singla, Manish B, et al.
Publicado: (2015) -
Worsened Fibrostenotic Outcomes in Eosinophilic Esophagitis Patients Due to COVID-19-Related Endoscopy Cancellations
por: Ocampo, Adolfo A., et al.
Publicado: (2022) -
Relapse of Eosinophilic Esophagitis on Dupilumab
por: Buendia, Matthew A., et al.
Publicado: (2022) -
Fibrostenotic strictures in Crohn’s disease
por: Yoo, Jun Hwan, et al.
Publicado: (2020)